RecruitingNCT03676647
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Retrospective-Prospective Collection of Thyroid Specimens After FNA
Sponsor
City of Hope Medical Center
Enrollment
22 participants
Start Date
Apr 25, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This trial studies how well the diagnostic deoxyribonucleic acid (DNA) methylation signature works in detecting thyroid cancer in patients with thyroid nodules. Using diagnostic testing, such as the diagnostic DNA methylation signature, may be a less invasive way to check for thyroid cancer.
Eligibility
Min Age: 19 Years
Inclusion Criteria3
- All patients undergoing FNA for thyroid nodule diagnosis.
- Any race and ethnicity are eligible for the study.
- Patient should have thyroid nodule(s) with indeterminate diagnosis after FNA (Bethesda category of indeterminate FNA \[III-V\]).
Interventions
OTHERDiagnostic DNA Methylation Signature
Undergo collection of tissue samples
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03676647